Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Mucopolysaccharidosis type II (MPS II), or Hunter's disease, is a rare genetic disorder caused by mutations in the iduronate sulphatase (IDS) gene.
• Accurate genetic diagnosis is crucial for understanding disease progression and enabling carrier testing.

Purpose of the Study:

• To identify the primary genetic mutations in the IDS gene in MPS II patients.
• To investigate the correlation between genotype and phenotype in MPS II.
• To establish reliable carrier testing for female relatives of affected individuals.

Main Methods:

• Genomic DNA analysis of the IDS gene in 57 unrelated MPS II patients.
• Identification of point mutations, including substitutions, deletions, insertions, and splice site mutations.
• Analysis of large deletions encompassing one or more exons of the IDS gene.

Main Results:

• Mutations were identified in 42 out of 57 patients, with 4 patients having complete IDS gene deletions.
• Numerous novel mutations were discovered, including nonsense, missense, insertion, deletion, and splice site mutations.
• Genotype-phenotype correlation was challenging in some cases, suggesting the need for further mRNA analysis.

Conclusions:

• The study identified a wide spectrum of IDS gene mutations in MPS II patients, many of which appear to be unique.
• The findings provide a basis for improved genetic diagnosis and carrier screening in MPS II families.
• Further research is needed to fully elucidate the impact of identified mutations on IDS mRNA and protein function.